THE EFFECT OF MENOPAUSAL HORMONE THERAPY ON CARDIOVASCULAR RISK

Main Article Content

Shoira Tulkinovna Ismoilova
Diyora Murodjon qizi Khalikova

Abstract

This article reviews the effect of menopausal hormone therapy (MHT) on the cardiovascular system based on clinical experience and an extensive review of the literature. The timing hypothesis, pathophysiological mechanisms associated with declining estrogen levels, and findings from modern randomized controlled trials are examined. The need to consider age, time since menopause, and individual risk factors when prescribing MHT is substantiated.


 

Article Details

Section
Articles

References

Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333.

Manson J. E., Chlebowski R. T., Stefanick M. L., Aragaki A. K., Rossouw J. E., Prentice R. L., et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310(13):1353–1368.

Hodis H. N., Mack W. J., Henderson V. W., Shoupe D., Budoff M. J., Hwang-Levine J., et al. Vascular effects of early versus late postmenopausal treatment with estradiol. The New England Journal of Medicine. 2016;374(13):1221–1231.

Boardman H. M. P., Hartley L., Eisinga A., Main C., Roqué i Figuls M., Bonfill Cosp X., et al. Hormone therapy for preventing cardiovascular disease in postmenopausal women. Cochrane Database of Systematic Reviews. 2015;(3):CD002229.

Lobo R. A., Pickar J. H., Stevenson J. C., Mack W. J., Hodis H. N. Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis. 2016;254:282–290.